ArmInfo.Negotiations are ongoing on the supply to Armenia of the Russian drug Triazavirin, which is being tested for the treatment of coronavirus. This was reported by TASS with reference to Alexander Petrov - chairman of the board of directors of the company Medsintez, which produces the medicine.
According to the source, the Triazavirin party was delivered to Turkmenistan. Previously, the drug was sent to China as humanitarian aid, where it is being tested for the treatment of coronavirus. <We are waiting for permission to import into South Korea, but they have difficulties with the customs legislation on unregistered drugs. Now we are discussing the issue of clinical trials with Italy. But this is also a long time, because they have different testing legislation than in China or Russia>, Petrov noted.
<Triazavirin> is a Russian direct-acting antiviral drug of the azoloazine family. According to the developers, it is effective against 15 types of flu. Developed by scientists of the Ural Federal University, Institute of Organic Synthesis named after I. Ya. Postovsky of the Ural Branch of the Russian Academy of Sciences and the Research Institute of Influenza of the Ministry of Health of Russia.